Although we validated key hits in patient-derived xenograft (PDX) models of breast and multiple breast cancer cell lines, the generalizability of these findings across all PLK1-driven cancers remains to be further tested in a broader panel of tumor types. Here, PLK1 is linked to neoplasm.